pharma · Duchenne Muscular Dystrophy · Gastroparesis · PCSA
Processa Pharmaceuticals
Processa Pharmaceuticals is a pharma organization headquartered in Hanover, USA. It trades on NYSE under ticker PCSA. Primary therapeutic focus areas include Duchenne Muscular Dystrophy, Gastroparesis, Necrobiosis Lipoid
Hanover, USA HQ
16 Employees
Public company Type
PCSA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Hanover, USA
- Employees
- 16
- Programs
- 8
- Drugs
- 2
- Patents
- 0
HT-100
Phase 2 · small molecule · Duchenne Muscular Dystrophy
HT-100 for Duchenne Muscular Dystrophy is a Phase 2 program (small_molecule) at Processa Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Internal code HALO-DMD-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Processa Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Duchenne Muscular Dystrophy
- Status
- terminated
- Trials
- 2